Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Transfusion|April 11, 2026
Impaired hematopoiesis affects apheresis and CAR T-cell product composition and treatment responseHanna Kuhn, Felix Korell, Angela Hückelhoven-Krauss, et al.
International Journal of Cancer|July 20, 2020
Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patientsFuli Fan, Hyeon Joo Yoo, Sophia Stock, et al.
Cytotherapy|March 27, 2019
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cellsLei Wang, Wenjie Gong, Sanmei Wang, et al.
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
International Journal of Molecular Sciences|May 22, 2019
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell MalignanciesHyeon Joo Yoo, Yibin Liu, Lei Wang, et al.
International Journal of Cancer|November 12, 2021
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cellsYi Liu, Sanmei Wang, Maria-Luisa Schubert, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.
Vaccines|February 26, 2022
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell TransplantationCaroline Pabst, Louise Benning, Nora Liebers, et al.
Pageof 5